Capital Flow Monitor · Sponsors · CIK 1873965
Belhaven Biopharma Inc.
84406 Winslow, Chapel Hill, NC, 27517 · 919-656-8658
Pharmaceuticals · Corporation· inc. DELAWARE true 2020
Fit score
—
Offering
$32.3M
Sold
$32.3M
% sold
100.0%
Investors
222
Min investment
$0
Exemption
506(b)
Filing history
| Filed | Form | Rule | Offering | Sold | % sold | Investors | |
|---|---|---|---|---|---|---|---|
| 2025-10-15 | D ·current | 506(b) | $32.3M | $32.3M | 100.0% | 222 | EDGAR ↗ |
Related persons
Executive officers, directors and promoters, as filed.
- Scott David Lyman — Executive Officer / Director, Chapel Hill, NC
- David Algon Neal — Executive Officer / Director, Chapel Hill, NC
- Wes Wheeler — Director, Chapel Hill, NC
- Derek Winstanly — Director, Chapel Hill, NC
Placement agents
- No sales compensation reported — direct raise.
Source: SEC EDGAR Form D. Self-reported by the issuer. Not investment advice.